Royal Bank of Canada’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,020
| Closed | -$164K | – | 7165 |
|
|
2024
Q2 | $164K | Buy |
4,020
+1,376
| +52% | +$56.1K | ﹤0.01% | 4537 |
|
|
2024
Q1 | $113K | Sell |
2,644
-19,985
| -88% | -$854K | ﹤0.01% | 4685 |
|
|
2023
Q4 | $959K | Buy |
22,629
+14,672
| +184% | +$622K | ﹤0.01% | 3218 |
|
|
2023
Q3 | $173K | Buy |
7,957
+3,907
| +96% | +$84.9K | ﹤0.01% | 4457 |
|
|
2023
Q2 | $128K | Buy |
4,050
+636
| +19% | +$20.1K | ﹤0.01% | 4701 |
|
|
2023
Q1 | $83K | Sell |
3,414
-4,736
| -58% | -$115K | ﹤0.01% | 4949 |
|
|
2022
Q4 | $257K | Buy |
8,150
+5,191
| +175% | +$164K | ﹤0.01% | 4216 |
|
|
2022
Q3 | $83K | Buy |
2,959
+480
| +19% | +$13.5K | ﹤0.01% | 4956 |
|
|
2022
Q2 | $66K | Sell |
2,479
-2,194
| -47% | -$58.4K | ﹤0.01% | 5131 |
|
|
2022
Q1 | $164K | Sell |
4,673
-14,305
| -75% | -$502K | ﹤0.01% | 4791 |
|
|
2021
Q4 | $615K | Buy |
18,978
+13,552
| +250% | +$439K | ﹤0.01% | 3801 |
|
|
2021
Q3 | $160K | Buy |
5,426
+3,012
| +125% | +$88.8K | ﹤0.01% | 4856 |
|
|
2021
Q2 | $62K | Buy |
+2,414
| New | +$62K | ﹤0.01% | 5412 |
|